Correction: Redefining attrition in multiple myeloma (MM): a Canadian Myeloma Research Group (CMRG) analysis

• Arleigh McCurdy,
• Hira Mian,
• Richard LeBlanc,
• Victor H. Jimenez-Zepeda,
• Jiandong Su,
• Esther Masih-Khan,
• Alissa Visram,
• Martha Louzada,
• Kevin Song,
• Darrell White,
• Michael Sebag,
• Julie Stakiw,
• Anthony Reiman,
• Muhammad Aslam,
• Debra Bergstrom,
• Rami Kotb,
• Rayan Kaedbey,
• Engin Gul,
• Donna Reece,
• Christopher P. Venner

Affiliations

Arleigh McCurdy

Ottawa Hospital Research Institute, The Ottawa Hospital

Hira Mian

Juravinski Cancer Center

Richard LeBlanc

Maisonneuve-Rosemont Hospital Research Centre, University of Montreal

Victor H. Jimenez-Zepeda

Arnie Charbonneau Cancer Institute, University of Calgary

Jiandong Su

Canadian Myeloma Research Group

Esther Masih-Khan

Canadian Myeloma Research Group

Alissa Visram

Ottawa Hospital Research Institute, The Ottawa Hospital

Martha Louzada

Department of Medicine, London Regional Cancer Center

Kevin Song

BC Cancer Agency, Vancouver General Hospital

Darrell White

Queen Elizabeth II Health Sciences Centre, Dalhousie University

Michael Sebag

Department of Medicine, McGill University

Julie Stakiw

Saskatoon Cancer Centre, University of Saskatchewan

Anthony Reiman

Department of Medicine, Saint John Regional Hospital

Muhammad Aslam

Department of Medical Oncology, Allan Blair Cancer Centre

Debra Bergstrom

Division of Hematology, Memorial University of Newfoundland

Rami Kotb

Department of Medical Oncology & Hematology, Cancer Care Manitoba

Rayan Kaedbey

Department of Medicine, Jewish General Hospital

Engin Gul

Canadian Myeloma Research Group

Donna Reece

Canadian Myeloma Research Group

Christopher P. Venner

BC Cancer Agency, Vancouver General Hospital